Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066898
Filing Date
2025-05-08
Accepted
2025-05-08 16:02:22
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rckt-20250331.htm   iXBRL 10-Q 1847851
2 EX-10.1 rckt-ex10_1.htm EX-10.1 167804
3 EX-31.1 rckt-ex31_1.htm EX-31.1 18311
4 EX-31.2 rckt-ex31_2.htm EX-31.2 18454
5 EX-32.1 rckt-ex32_1.htm EX-32.1 14711
6 GRAPHIC img174782773_0.jpg GRAPHIC 962751
7 GRAPHIC img174782773_1.jpg GRAPHIC 1469571
8 GRAPHIC img174782773_2.jpg GRAPHIC 1198924
9 GRAPHIC img174782773_3.jpg GRAPHIC 787996
  Complete submission text file 0000950170-25-066898.txt   20339088

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rckt-20250331.xsd EX-101.SCH 1396564
94 EXTRACTED XBRL INSTANCE DOCUMENT rckt-20250331_htm.xml XML 1724485
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 25925838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)